Cochrane Abstracts
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension Edited (no change to conclusions)
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Angiotensin Converting Enzyme (ACE) Inhibitors Versus Angiotensin Receptor Blockers for Primary Hypertension Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438626/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension_Edited__no_change_to_conclusions_. Accessed 31 March 2020.
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438626/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension_Edited__no_change_to_conclusions_. Accessed March 31, 2020.
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension Edited (no change to conclusions). In Cochrane Abstracts Retrieved March 31, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/438626/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension_Edited__no_change_to_conclusions_
Angiotensin Converting Enzyme (ACE) Inhibitors Versus Angiotensin Receptor Blockers for Primary Hypertension Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2020 March 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438626/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension Edited (no change to conclusions)
ID - 438626
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438626/all/Angiotensin_converting_enzyme__ACE__inhibitors_versus_angiotensin_receptor_blockers_for_primary_hypertension_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -